Since the release of the 《 "Healthy China 2030" Planning Outline》 in 2016, one third of the time has passed. Looking back at the past year, From the 《Health Insurance Management Measures》in November 2019, to the 《Opinions on Promoting the Development of Commercial Insurance in the Social Service Field》in January this year, then to the 《Notice on Regulating the Health Management Services of Insurance Companies (Draft for Comment)》in May … A series of industrial new policies around health insurance will be released intensively in 2020.
On the other hand, the sweeping of COVID-19 has unprecedentedly stimulated the awareness of health and insurance among Chinese. With the dramatic changes on the demand side, various capitals are accelerating the already fiercely competitive health insurance market. Admittedly, challenges always coexist with opportunities. The big health and insurance market of China is far from being released, allowing any company to exert its abilities. How to grasp the policy dividend? How to achieve funding control more effectively? How to open up new ideas for product differentiation? How to use digital technology to reshape the business pattern? The latest interpretations of these issues will be presented at the 4th 2020 Asia Pacific Health Insurance
As the only international summit in China that integrates hospitals, pharmaceutical companies and other institutions to deeply analyze the health insurance industry chain, this summit is another practice in Chinese health insurance industry which is seeking cross-border, cooperation and win-win model. From the perspective of the great changes in big health industry, the summit will join hands with more than 350 experts and scholars from different fields , including insurance institutions, medical institutions, pharmaceutical companies, PBM, insurance technology, medical big data, Wearable devices, etc., help create a new driving force for the integrated development of health, insurance, and medical care.